SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • Driven by diligence

          Canara Robeco's Cheenu Gupta believes in knowing her companies inside out, and never being too sure of one’s analysis 

          Anishaa Kumar - March 01, 2021
        • When the sun shines

          Non-executive director Sudhir Valia sells Sun Pharma stock worth ₹2.91 billion held by Raksha Valia

          Shailaja Mohapatra - January 16, 2021
        • When Wind Met Sun

          In 2015, Dilip Shanghvi raised eyebrows when he invested Rs.18 billion in Suzlon

          Krishna Gopalan - July 18, 2020
        • What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?

          Within a year, the investing legend has doubled down on his latest pharma bet

          Himanshu Kakkar - May 23, 2020
        • New growth model

          Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?

          Kripa Mahalingam - July 26, 2019
        • Tricky Transition

          Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs

          N Mahalakshmi - July 16, 2019
        • The Eclipse of A Star

          Investors worry about poor corporate governance practices at Sun Pharma and price erosion in the US generics market

          Prathamesh Mulye - March 25, 2019
        • Content Farming

          OTT players are splurging on 'Originals' to stay ahead

          N Mahalakshmi - March 18, 2019
        • Seeking a Safe Haven

          As the market tumbles, mutual fund managers recommend pharma, private banks and specialty chemicals to tide over the volatility

          Prathamesh Mulye - January 08, 2019
        • Uphill Climb

          The pharma industry has to deal with poor road connectivity and an unskilled labour force in Sikkim, but it seems to have made peace with the mountains

          Himanshu Kakkar - January 25, 2019